There are 126 results for 'Key Finding'

Bowen Gu to speak at RI Americas 2018

On 6 December, Bowen Gu, Investor Engagement Researcher at the Access to Medicine Foundation, will speak at the RI Americas Conference in New York, US...

https://accesstomedicinefoundation.org/events/bowen-gu-to-speak-at-ri-americas-2018

The context

The discovery of vaccines has played a central role in some of the most significant achievements in global public health. Vaccination protects childre...

https://accesstomedicinefoundation.org/access-to-vaccines-index/about-the-index/the-context

Majority of key on-patent products have access initiatives, but these are limited in reach

From the 20 companies evaluated, the Index has identified 53 products that are critical candidates for companies’ access initiatives. The Index uses f...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/majority-of-key-on-patent-products-have-access-initiatives-but-these-are-limited-in-reach

Majority of key on-patent products have access initiatives, but these are limited in reach

From the 20 companies evaluated, the Index has identified 53 products that are critical candidates for companies’ access initiatives. The Index uses f...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/majority-of-key-on-patent-products-have-access-initiatives-but-these-are-limited-in-reach

On-patent products: how do pharmaceutical companies use pricing, licensing and donations to improve access to key medicines?

Low- and middle-income countries are home to the majority of the world’s poorest people. Whether medicines, vaccines and other products reach the peop...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/on-patent-products-how-do-pharmaceutical-companies-use-pricing-licensing-and-donations-to-improve-access-to-key-medicines

On-patent products: how do pharmaceutical companies use pricing, licensing and donations to improve access to key medicines?

Low- and middle-income countries are home to the majority of the world’s poorest people. Whether medicines, vaccines and other products reach the peop...

https://accesstomedicinefoundation.org/access-to-medicine-index/results/on-patent-products-how-do-pharmaceutical-companies-use-pricing-licensing-and-donations-to-improve-access-to-key-medicines

Who we are

The Access to Medicine Foundation is an independent non-profit organisation. We analyse how the world's largest pharmaceutical companies are addressin...

https://accesstomedicinefoundation.org/about-us/who-we-are

Commits to registering new products in poorer countries in 12 months

Parallel dossier preparation to facilitate faster registration.

https://accesstomedicinefoundation.org/access-to-medicine-index/best-innovative-practices/commits-to-registering-new-products-in-poorer-countries-in-12-months

Systematic approach to identify access challenges

A comprehensive Access Planning Framework to determine current access levels in countries, and how its initiatives contribute to access.

https://accesstomedicinefoundation.org/access-to-medicine-index/best-innovative-practices/systematic-approach-to-identify-access-challenges

Strong transparency on where products are registered

Only company to publish full details of the registration status of its products. 

https://accesstomedicinefoundation.org/access-to-medicine-index/best-innovative-practices/strong-transparency-on-where-products-are-registered